Necessity of Pelvic Lymph Node Irradiation in Patients with Recurrent Prostate Cancer after Radical Prostatectomy in the PSMA PET/CT Era: A Narrative Review.
Naeim NabianReza GhalehtakiFelipe CouñagoPublished in: Biomedicines (2022)
The main prostate cancer (PCa) treatments include surgery or radiotherapy (with or without ADT). However, none of the suggested treatments eliminates the risk of lymph node metastases. Conventional imaging methods, including MRI and CT scanning, are not sensitive enough for the diagnosis of lymph node metastases; however, the novel imaging method, PSMA PET/CT scanning, has provided valuable information about the pelvic LN involvement in patients with recurrent PCa (RPCa) after radical prostatectomy. The high sensitivity and negative predictive value enable accurate N staging in PCa patients. In this narrative review, we summarize the evidence on the treatment and extent of radiation in prostate-only or whole-pelvis radiation in patients with positive and negative LN involvement on PSMA PET/CT scans.
Keyphrases
- pet ct
- radical prostatectomy
- prostate cancer
- lymph node
- high resolution
- positron emission tomography
- contrast enhanced
- neoadjuvant chemotherapy
- sentinel lymph node
- computed tomography
- end stage renal disease
- radiation induced
- rectal cancer
- chronic kidney disease
- magnetic resonance imaging
- early stage
- minimally invasive
- newly diagnosed
- electron microscopy
- prognostic factors
- radiation therapy
- locally advanced
- magnetic resonance
- image quality
- mass spectrometry
- patient reported outcomes
- squamous cell carcinoma
- coronary artery disease
- acute coronary syndrome
- smoking cessation